CVE-2023-41150: F-Revocrm

Medium severity, CVSS 5.4. EPSS: 0.4% chance of exploitation in the next 30 days.

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is using the product.

Affected products

• F-Revocrm F-Revocrm: from 7.3, up to and including 7.3.8

Published 2023-09-06. Last modified 2026-06-17.